Literature DB >> 16951298

Exercise and restless legs syndrome: a randomized controlled trial.

Melissa McManama Aukerman1, Douglas Aukerman, Max Bayard, Fred Tudiver, Lydia Thorp, Beth Bailey.   

Abstract

BACKGROUND AND OBJECTIVES: Restless legs syndrome (RLS) is a common, underdiagnosed neurological movement disorder of undetermined etiology. The primary treatments for restless legs syndrome are pharmacological. To date, no randomized controlled trials have examined the effectiveness of an exercise program on the symptoms of RLS.
METHODS: Study participants (N = 41) were randomized to either exercise or control groups. 28 participants (average age 53.7; 39% males) were available and willing to begin the 12-week trial. The exercise group was prescribed a conditioning program of aerobic and lower-body resistance training 3 days per week. Restless legs symptoms were assessed by the International RLS Study Group (IRLSSG) severity scale and an ordinal scale of RLS severity at the beginning of the trial, and at 3, 6, 9, and 12 weeks.
RESULTS: Twenty-three participants completed the trial. At the end of the 12 weeks, the exercise group (N = 11) had a significant improvement in symptoms compared with the control group (N = 12) (P = .001 for the IRLSSG severity scale and P < .001 for the ordinal scale).
CONCLUSIONS: The prescribed exercise program was effective in improving the symptoms of RLS.

Entities:  

Mesh:

Year:  2006        PMID: 16951298     DOI: 10.3122/jabfm.19.5.487

Source DB:  PubMed          Journal:  J Am Board Fam Med        ISSN: 1557-2625            Impact factor:   2.657


  46 in total

Review 1.  Restless legs syndrome: a comprehensive overview on its epidemiology, risk factors, and treatment.

Authors:  Paul Yeh; Arthur S Walters; John W Tsuang
Journal:  Sleep Breath       Date:  2011-10-26       Impact factor: 2.816

2.  Recent advances in the diagnosis, genetics and treatment of restless legs syndrome.

Authors:  Claudia Trenkwalder; Birgit Högl; Juliane Winkelmann
Journal:  J Neurol       Date:  2009-04-27       Impact factor: 4.849

3.  A 68-year-old woman with sleep-onset insomnia.

Authors:  Norman Wolkove; Marc Baltzan
Journal:  CMAJ       Date:  2013-09-23       Impact factor: 8.262

Review 4.  The treatment of restless legs syndrome and periodic limb movement disorder in adults--an update for 2012: practice parameters with an evidence-based systematic review and meta-analyses: an American Academy of Sleep Medicine Clinical Practice Guideline.

Authors:  R Nisha Aurora; David A Kristo; Sabin R Bista; James A Rowley; Rochelle S Zak; Kenneth R Casey; Carin I Lamm; Sharon L Tracy; Richard S Rosenberg
Journal:  Sleep       Date:  2012-08-01       Impact factor: 5.849

5.  Physical activity and self-reported symptoms of insomnia, restless legs syndrome, and depression: the comprehensive dialysis study.

Authors:  Shuchi Anand; Kirsten L Johansen; Barbara Grimes; George A Kaysen; Lorien S Dalrymple; Nancy G Kutner; Glenn M Chertow
Journal:  Hemodial Int       Date:  2012-07-20       Impact factor: 1.812

6.  Decreased Symptoms without Augmented Skin Blood Flow in Subjects with RLS/WED after Vibration Treatment.

Authors:  Ulrike H Mitchell; Sterling C Hilton; Erik Hunsaker; Jan Ulfberg
Journal:  J Clin Sleep Med       Date:  2016-07-15       Impact factor: 4.062

Review 7.  Restless Legs Syndrome and Other Movement Disorders of Sleep-Treatment Update.

Authors:  Aaro V Salminen; Juliane Winkelmann
Journal:  Curr Treat Options Neurol       Date:  2018-11-09       Impact factor: 3.598

8.  In Search of a Good Night's Sleep: Hormones, Mind, Movement, and Breath.

Authors:  Cindy Geyer
Journal:  Am J Lifestyle Med       Date:  2017-12-28

Review 9.  Treatment of restless legs syndrome.

Authors:  Cynthia L Comella
Journal:  Neurotherapeutics       Date:  2014-01       Impact factor: 7.620

10.  The relationship between physical activity, restless legs syndrome, and health-related quality of life in type 2 diabetes.

Authors:  Thiago Medeiros da Costa Daniele; Veralice Meireles Sales de Bruin; Adriana Costa e Forte; Débora Siqueira Nobre de Oliveira; Clara Mota Randal Pompeu; Pedro Felipe Carvalhedo de Bruin
Journal:  Endocrine       Date:  2012-12-01       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.